These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3144646)

  • 1. EDTA chelation therapy in chronic degenerative disease.
    Olszewer E; Carter JP
    Med Hypotheses; 1988 Sep; 27(1):41-9. PubMed ID: 3144646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The improvement in renal function following EDTA chelation and multi-vitamin-trace mineral therapy: a study in creatinine clearance.
    Sehnert KW; Clague AF; Cheraskin E
    Med Hypotheses; 1984 Nov; 15(3):301-4. PubMed ID: 6441110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDTA chelation therapy in the treatment of vascular disease.
    Chappell LT; Janson M
    J Cardiovasc Nurs; 1996 Apr; 10(3):78-86. PubMed ID: 8820322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial.
    van Rij AM; Solomon C; Packer SG; Hopkins WG
    Circulation; 1994 Sep; 90(3):1194-9. PubMed ID: 8087928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent failure of edetic acid chelation therapy for the treatment of coronary atherosclerosis.
    Wirebaugh SR; Geraets DR
    DICP; 1990 Jan; 24(1):22-5. PubMed ID: 2105562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease.
    Olszewer E; Sabbag FC; Carter JP
    J Natl Med Assoc; 1990 Mar; 82(3):173-7. PubMed ID: 2108254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EDTA chelation therapy meets evidence-based medicine.
    Lamas GA; Hussein SJ
    Complement Ther Clin Pract; 2006 Aug; 12(3):213-5. PubMed ID: 16835033
    [No Abstract]   [Full Text] [Related]  

  • 8. Chelation therapy of atherosclerosis.
    Rathmann KL; Golightly LK
    Drug Intell Clin Pharm; 1984 Dec; 18(12):1000-3. PubMed ID: 6439540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inefficacy of EDTA chelation therapy for coronary atherosclerosis.
    McGillem MJ; Mancini GB
    N Engl J Med; 1988 Jun; 318(24):1618-9. PubMed ID: 3131677
    [No Abstract]   [Full Text] [Related]  

  • 10. Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by Chelation (EDTA).
    RUKAVINA JG; MENDELSON C; PRICE JM; BROWN RR; JOHNSON SA
    J Invest Dermatol; 1957 Oct; 29(4):273-88. PubMed ID: 13491891
    [No Abstract]   [Full Text] [Related]  

  • 11. EDTA chelation therapy for arteriosclerotic heart disease.
    Med Lett Drugs Ther; 1981 May; 23(11):51. PubMed ID: 6785565
    [No Abstract]   [Full Text] [Related]  

  • 12. EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.
    Born T; Kontoghiorghe CN; Spyrou A; Kolnagou A; Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):11-7. PubMed ID: 22991933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.
    Lowe GD
    Br Med J (Clin Res Ed); 1983 Apr; 286(6373):1262-4. PubMed ID: 6404416
    [No Abstract]   [Full Text] [Related]  

  • 14. Chelation therapy in the JCR:LA-cp rat: experimental assessment of a putative antiatherosclerotic treatment.
    O'Brien SF; Kelly SE; Dolphin PJ; Russell JC
    Clin Invest Med; 2000 Apr; 23(2):124-31. PubMed ID: 10852662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic industrial exposure to lead in 63 subjects. II. Evaluation of chelation therapy.
    Strickland GT; Hwang YF; Chang NK; Blackwell RQ
    Southeast Asian J Trop Med Public Health; 1976 Dec; 7(4):569-74. PubMed ID: 828980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant therapy in the aging process.
    Deucher GP
    EXS; 1992; 62():428-37. PubMed ID: 1450604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelation therapy in the treatment of cardiovascular diseases.
    Ibad A; Khalid R; Thompson PD
    J Clin Lipidol; 2016; 10(1):58-62. PubMed ID: 26892121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EDTA chelation therapy, without added vitamin C, decreases oxidative DNA damage and lipid peroxidation.
    Roussel AM; Hininger-Favier I; Waters RS; Osman M; Fernholz K; Anderson RA
    Altern Med Rev; 2009 Mar; 14(1):56-61. PubMed ID: 19364193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences on the treatment of cerebral insufficiency and peripheral circulation disorders with the test preparation EP 50-100].
    Bock KJ
    Med Welt; 1972 Feb; 23(8):273-5. PubMed ID: 5012543
    [No Abstract]   [Full Text] [Related]  

  • 20. EDTA chelation for calcific band keratopathy: results and long-term follow-up.
    Najjar DM; Cohen EJ; Rapuano CJ; Laibson PR
    Am J Ophthalmol; 2004 Jun; 137(6):1056-64. PubMed ID: 15183790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.